Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice

Citation

Jain, A, Chitturi, S, Peters, G et al. 2021, 'Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice', World Journal of Hepatology, vol. 13, no. 9, pp. 1132-1142.

Year

2021

Updated:  30 March 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers